Hinge Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
Hinge Health, Inc. (HNGE), an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on February 10, 2026. The filing announces the release of financial results for the fourth quarter and the full year ended December 31, 2025. A conference call to discuss these results was held on the date of the report.
Key Financial Metrics
The provided filing text serves as a notification of the results release and does not contain specific numerical data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document. The filing notes that the accompanying press release (Exhibit 99.1) contains non-GAAP financial measures and reconciliations to GAAP equivalents, but the specific figures are not included in the text provided.
Material Changes
The filing text does not provide specific data to compare current period performance against prior comparable periods. Investors must refer to the referenced press release and investor materials for details on material changes in financial condition or results of operations.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, and specific risk factors are not detailed in this Form 8-K text. The company directs investors to its investor relations website (ir.hingehealth.com) for supplemental materials and compliance with Regulation FD. The filing includes standard disclaimers that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" under the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific revenue and net income figures for Q4 and FY 2025 in the attached Press Release (Exhibit 99.1).
- Review the reconciliation of non-GAAP financial measures to GAAP equivalents provided in the press release.
- Check the investor relations website for supplemental materials and the transcript of the February 10, 2026 conference call.
- Confirm the company's status as an emerging growth company and any election regarding extended transition periods for accounting standards.